Stockscreener 앱 받기
2.87
5.51%
0.15
시간 외 거래:
2.87
전일 마감가:
$2.72
열려 있는:
$2.85
하루 거래량:
171.29K
Relative Volume:
1.62
시가총액:
$160.44M
수익:
$26.03M
순이익/손실:
$-17.12M
주가수익비율:
-9.2283
EPS:
-0.311
순현금흐름:
$-24.53M
1주 성능:
+2.50%
1개월 성능:
-1.03%
6개월 성능:
+82.80%
1년 성능:
+258.75%
1일 변동 폭
$2.78
$3.00
1주일 범위
$2.56
$3.03
52주 변동 폭
$0.51
$3.28
코넥트 바이오파마 Stock (CNTB) Company Profile
명칭
Connect Biopharma Holdings Ltd
전화
858-727-1040
주소
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.87 | 152.06M | 26.03M | -17.12M | -24.53M | -0.311 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
코넥트 바이오파마 Stock (CNTB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 개시 | Lake Street | Buy |
| 2025-10-31 | 개시 | BTIG Research | Buy |
| 2025-06-12 | 개시 | H.C. Wainwright | Buy |
| 2024-03-04 | 개시 | H.C. Wainwright | Buy |
| 2021-04-13 | 개시 | Jefferies | Buy |
| 2021-04-13 | 개시 | Piper Sandler | Overweight |
| 2021-04-13 | 개시 | SVB Leerink | Outperform |
모두보기
코넥트 바이오파마 주식(CNTB)의 최신 뉴스
Connect Biopharma (CNTB) director linked fund reports 12M-share holding - Stock Titan
Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight – Company AnnouncementFT.com - Financial Times
[Form 3] Connect Biopharma Holdings Ltd Initial Statement of Beneficial Ownership - Stock Titan
Connect Biopharma (CNTB) president discloses share and option holdings - Stock Titan
Connect Biopharma (CNTB) CEO details stock option and share holdings - Stock Titan
Connect Biopharma (CNTB) SVP lists Ordinary Shares and option grants - Stock Titan
Connect Biopharma (NASDAQ: CNTB) director reports initial share and option holdings - Stock Titan
Connect Biopharma (CNTB) director lists stock option and share stakes - Stock Titan
Connect Biopharma (NASDAQ: CNTB) director reports initial stock option holdings - Stock Titan
Kleanthis Gabriel Xanthopoulos Net Worth (2026) - GuruFocus
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pueblo Chieftain
Connect Biopharma Touts “Next-Gen Dupixent” Rademikibart, Near-Term Asthma/COPD Readouts - MarketBeat
Severe Asthma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Lanier Biotherapeutics, Bio-Thera Solutions, Kinaset Therapeutics, CSPC ZhongQi Pharma - StreetInsider
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Simcere’s rademikibart AD study selected for AAD presentation - Investing.com
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting - Bitget
Results from Phase 3 Study of Rademikibart in - GlobeNewswire
Severe eczema drug from Connect Biopharma lands late-breaking AAD slot - Stock Titan
COYA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - The Manila Times
CNTB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GNLX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SELX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CNTB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
UCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CNTB Technical Analysis & Stock Price Forecast - Intellectia AI
Connect Biopharma Touts Rademikibart as Fast-Acting Option for Acute Asthma, COPD Flare-Ups at Conference - MarketBeat
BML Capital Management LLC Sells 554,058 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
KraneShares CSI China Internet ETF $KWEB Shares Purchased by Aurora Investment Managers LLC. - Defense World
Invesco QQQ $QQQ Stock Position Lessened by Concentrum Wealth Management - Defense World
JD.com, Inc. $JD Shares Acquired by Aurora Investment Managers LLC. - Defense World
BML Capital Management LLC Makes New Investment in ImageneBio, Inc. $IMA - Defense World
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Manila Times
Watch Connect Biopharma's Oppenheimer health conference talk online - Stock Titan
Wubin Pan and BioFortune Inc. disclose 10.8% stake in Connect Biopharma (CNTB) - Stock Titan
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - Financial Times
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
CNTB PE Ratio & Valuation, Is CNTB Overvalued - Intellectia AI
What is HC Wainwright's Forecast for CNTB FY2028 Earnings? - MarketBeat
Equities Analysts Offer Predictions for CNTB FY2030 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Analysts’ Top Healthcare Picks: Context Therapeutics (CNTX), Connect Biopharma Holdings (CNTB) - The Globe and Mail
3 Promising Penny Stocks With Market Caps Up To $400M - Yahoo Finance
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OPAL Fuels Inc. (NASDAQ:OPAL) Given Average Recommendation of “Reduce” by Analysts - Defense World
NVR, Inc. (NYSE:NVR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Contrasting Joint Stock Company Kaspi.kz (NASDAQ:KSPI) & PagSeguro Digital (NYSE:PAGS) - Defense World
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7%What's Next? - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7% – What’s Next? - Defense World
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
코넥트 바이오파마 (CNTB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):